#MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of #Hepatocellular Carcinoma
http://oncology.jamanetwork.com/mobile/article.aspx?articleid=2553752
Conclusions and Relevance In patients with cirrhosis at high-risk of HCC, screening that used MRI with liver-specific contrast resulted in a higher HCC detection rate and lower false-positive findings compared with US. With MRI screening, most of the cancers detected were at very early stage, which was associated with a high chance of curative treatments and favorable survival of patients. Whether surveillance with MRI would reduce mortality from HCC in high-risk patients requires further investigation.
http://oncology.jamanetwork.com/mobile/article.aspx?articleid=2553752
Conclusions and Relevance In patients with cirrhosis at high-risk of HCC, screening that used MRI with liver-specific contrast resulted in a higher HCC detection rate and lower false-positive findings compared with US. With MRI screening, most of the cancers detected were at very early stage, which was associated with a high chance of curative treatments and favorable survival of patients. Whether surveillance with MRI would reduce mortality from HCC in high-risk patients requires further investigation.
Jamanetwork
HCC Surveillance With MRI
This clinical trial examines the hepatocellular carcinoma detection rate using ultrasonography compared with magnetic resonance imaging in patients with cirrhosis who are at high risk for hepatocellular carcinoma.